In the FDA guidance about inspections during Covid19, the agency described the metrics and rating system to determine a Covid19 advisory levels for locations where prioritised domestic inspections, which generally includes pre-approval and survilance inspections are needed. This advisory level dictates what regulatory activities can occur within that geographic region.
According to the guidance, there are three main catogories of regulatory activities possible for priritised domestic inspections. They include
-mission inspections critical only
-all inspections with caveats to help protect staff who have self identified as being in a vulnerable population
-resumption of all regulatory activities